Detalhe da pesquisa
1.
High-resolution and quantitative spatial analysis reveal intra-ductal phenotypic and functional diversification in pancreatic cancer.
J Pathol
; 262(1): 76-89, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37842959
2.
Identification of RAD17 as a candidate cancer predisposition gene in families with histories of pancreatic and breast cancers.
BMC Cancer
; 24(1): 723, 2024 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38872153
3.
Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells.
Bioorg Med Chem Lett
; 79: 129066, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410591
4.
Targeting USP13-mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non-small cell lung cancer.
Int J Cancer
; 148(10): 2579-2593, 2021 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210294
5.
Structure-Activity Relationship (SAR) Study of Spautin-1 to Entail the Discovery of Novel NEK4 Inhibitors.
Int J Mol Sci
; 22(2)2021 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33435251
6.
ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework.
NPJ Precis Oncol
; 8(1): 70, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485987
7.
Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib.
Cancers (Basel)
; 15(9)2023 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174055
8.
Peripheral precocious puberty in Li-Fraumeni syndrome: a case report and literature review of pure androgen-secreting adrenocortical tumors.
J Med Case Rep
; 17(1): 195, 2023 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37179382
9.
The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer.
Cell Death Dis
; 13(7): 611, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840561
10.
USP13 controls the stability of Aurora B impacting progression through the cell cycle.
Oncogene
; 39(37): 6009-6023, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32772043
11.
In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis.
Pathogens
; 9(6)2020 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580355
12.
Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages.
J Control Release
; 299: 107-120, 2019 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30797866
13.
CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition.
Oncogene
; 38(31): 5933-5941, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31285551
14.
Production of a mono-biotinylated EGFR nanobody in the E. coli periplasm using the pET22b vector.
BMC Res Notes
; 11(1): 751, 2018 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30348204
15.
Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer.
Oncotarget
; 9(22): 16110-16123, 2018 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29662630
16.
Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer.
Oncotarget
; 9(47): 28731-28744, 2018 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29983892
17.
Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib.
Oncotarget
; 8(36): 60094-60108, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28947956
18.
Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer.
Oncotarget
; 7(3): 3068-83, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689995
19.
Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2.
Cell Death Dis
; 7(12): e2560, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28005077
20.
Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
Transl Lung Cancer Res
; 9(1): 1-3, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32206546